女性血小板与男性血小板功能活性不同:对输血实践和创伤性凝血病治疗的启示
研究纳入健康志愿者12例绝经前女性、13例绝经后女性和18例同龄男性,比较血小板对ADP和PAF的聚集与活化反应。女性血小板(绝经前+绝经后合并)ADP刺激后聚集增加,且女性血小板ADP活化强而男性血小板PAF活化强,存在差异。雌二醇孵育后,男性血小板PAF活化接近女性水平,且男女血小板PAF活化均增强。作者认为这或可解释创伤性凝血病中止血潜能的性别差异,并质疑输血时是否应考虑供者血小板性别,雌二醇或可成为创伤性凝血病的新型治疗辅助。
要点
- 女性血小板(绝经前+绝经后合并)对ADP刺激的聚集反应较男性血小板增加。
- 女性血小板以ADP活化为主,男性血小板以PAF活化为主,纤维蛋白原受体表达存在性别差异。
- 雌二醇孵育后男性血小板PAF活化接近女性(绝经前+绝经后合并)水平,男女血小板PAF活化均增强。
- 作者认为该发现或可解释创伤性凝血病止血潜能的性别差异,并质疑输血时是否应考虑供者血小板性别。
- 作者提出雌二醇或可作为创伤性凝血病的新型治疗辅助。
适用人群与场景
- 健康志愿者:绝经前女性(≤54岁)、绝经后女性(>54岁)及同龄男性。
研究设计与关键结果
- 研究类型为健康志愿者血小板功能实验室研究;纳入12例绝经前女性、13例绝经后女性和18例同龄男性。
- 女性血小板(绝经前+绝经后合并)ADP刺激后聚集较男性血小板增加。
- 男女血小板纤维蛋白原受体表达存在差异:女性血小板(绝经前+绝经后合并)ADP活化强,男性血小板PAF活化强。
- 雌二醇孵育后,男性血小板PAF活化接近女性(绝经前+绝经后合并)水平,且男女血小板PAF活化均增强。
证据类型、等级与局限
- 证据类型:健康志愿者实验室研究(血小板聚集仪与流式细胞术)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该发现或可解释创伤性凝血病中止血潜能的性别差异,并质疑输血时是否应考虑供者血小板性别。
- 作者提出雌二醇或可作为创伤性凝血病的新型治疗辅助。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Females are hypercoagulable and have survival benefit in trauma-induced coagulopathy (TIC). The mechanism for this sex-specific hypercoagulability is unknown. Platelets and platelet function are central in providing hemostatic potential and are the largest contributor to clot strength. Ligands (adenosine diphosphate [ADP] and platelet-activating factor [PAF]) bind distinct platelet receptors to potentiate activation and aggregation. We hypothesize that female platelets have a differential response to ADP and PAF, resulting in greater aggregation and activation compared to males, and that estradiol pretreatment of male or female platelets enhances this activity.
METHODS: Platelets were collected from healthy volunteers: premenopausal/postmenopausal females (≤54 years, >54 years) and similarly aged males. Platelet aggregometry and flow cytometry (fibrinogen binding capacity) were examined. After treatment with ADP or PAF, platelet aggregation was assessed with Chronolog and activation assessed by CD41 receptor surface expression using flow cytometry. Aggregation and activation were again assessed after platelet pretreatment with estradiol.
RESULTS: Healthy volunteers included 12 premenopausal and 13 postmenopausal females and 18 similarly aged males. Female platelets (combined premenopausal and postmenopausal) had increased aggregation with ADP stimulation, as compared to male platelets. Male and female platelets had differential fibrinogen receptor expression, with female platelets (combined premenopausal and postmenopausal) demonstrating robust activation with ADP versus male platelets with PAF. In the presence of estradiol incubation, male platelets' activation with PAF approximated that of females (combined premenopausal and postmenopausal) and activation with PAF was enhanced in both male and female platelets.
CONCLUSION: Male and female platelets have differential response to stimuli, suggesting sex-dependent signaling and cellular activation. Female platelets have both increased aggregation and activation potential, and estradiol pretreatment feminizes male platelets to approximate female platelet activation with PAF. These findings offer potential explanation for sex-based differences in hemostatic potential in TIC and question whether donor sex of transfused platelets should be considered in resuscitation. Estradiol may also serve as a novel therapeutic adjunct in TIC.
参考来源
- Coleman JR, Moore EE, Kelher MR, et al. Female platelets have distinct functional activity compared with male platelets: Implications in transfusion practice and treatment of trauma-induced coagulopathy. J Trauma Acute Care Surg. 2019. PMID: 31162329. doi:10.1097/TA.0000000000002398
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。